 |
Articles: Drug Approvals |
Prior Articles
Unimed pharmaceuticals, llc, decides not to file a patent infringement suit at this time against perrigo israel pharmaceuticals, ltd. following the receipt of a paragraph iv certification for a generic formulation of androgel 1%
Solvay, 07/20/09
Free full text
Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel
Mylan, 07/17/09 Taro Receives Patent for Ovide(R)
Taro Pharmaceuticals USA, 07/16/09
Free full text
Covidien Announces Health Canada Approval for its Generic Myocardial Perfusion Imaging Kit
Covidien, 07/15/09 One-dose emergency contraceptive approved by FDA
American Pharmacists Association, 07/14/09
Free full text
Safety and Security
PharmExec, 07/14/09 Boston Scientific Announces European Approval for Its LATITUDE Patient Management System
Boston Scientific, 07/14/09
Free full text
FDA Approves Plan B One-Step, a New One-Pill Emergency Contraceptive
Teva Pharmaceutical Industries, 07/14/09
Free full text
New therapeutic option for heartburn
BayNews International, 07/13/09
Free full text
Pathways to Approval of Pediatric Cardiac Devices in the United States: Challenges and Solutions
Pediatrics, 07/10/09 Bayer submits first-in-class estradiol-based oral contraceptive for approval in the U.S.
BayNews International, 07/09/09
Free full text
Warfarin Interactions With Substances Listed in Drug Information Compendia and in the FDA-Approved Label for Warfarin Sodium
Clinical Pharmacology & Therapeutics, 07/09/09 Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
Watson Pharmaceuticals, 07/09/09
Free full text
Sanofi Gets Green Light on Blockbuster Heart Treatment
PharmExec, 07/09/09 Japanese Ministry of Health approves Rasilez, a first-in-class direct renin inhibitor, for the treatment of high blood pressure
Novartis, 07/09/09
Free full text
Zoledronic acid (Reclast): Bisphosphonate approved for the prevention of osteoporosis in postmenopausal women
Formulary, 07/08/09 European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.'s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
Cell Therapeutics, 07/08/09
Free full text
Synthon First Generic Filer for Xyzal Oral Solution
Synthon, 07/08/09
Free full text
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex
Mylan, 07/08/09 Tolvaptan (Samsca): Vasopressin receptor antagonist approved for the treatment of clinically significant hypervolemic and euvolemic hyponatremia
Formulary, 07/07/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|
